PT-141 (Bremelanotide): A Melanocortin-Based Approach to Sexual Dysfunction
A clinical guide to PT-141 (bremelanotide): how this melanocortin receptor agonist works, what the Phase 3 evidence shows for hypoactive sexual desire disorder, and which biomarkers to monitor.